**Core Concept**
Ondansetron is a selective serotonin 5-HT3 receptor antagonist primarily used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. It acts by blocking the 5-HT3 receptors in the chemoreceptor trigger zone (CTZ) of the brain.

**Why the Correct Answer is Right**
Ondansetron is not a dopamine antagonist; it does not affect the dopaminergic pathways involved in nausea and vomiting. Instead, it selectively binds to and blocks the 5-HT3 receptors, which are activated by serotonin and contribute to the emetic response. This action is distinct from dopamine antagonists like metoclopramide, which also prevent nausea and vomiting but through a different mechanism.

**Why Each Wrong Option is Incorrect**
**Option A:** Ondansetron is indeed the drug of choice for chemotherapy-induced vomiting due to its efficacy and safety profile.
**Option C:** Ondansetron is a 5-HT3 antagonist, which is its primary mechanism of action in preventing nausea and vomiting.
**Option D:** Ondansetron does act on the CTZ, specifically by blocking the 5-HT3 receptors located in this region, which plays a crucial role in the emetic response.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that ondansetron is effective in preventing nausea and vomiting caused by a wide range of stimuli, including chemotherapy, radiation therapy, and surgery. However, it may not be as effective in patients with underlying conditions such as gastroesophageal reflux disease (GERD) or in those taking certain medications that can interact with ondansetron.

**✓ Correct Answer: B. Dopamine antagonist**